Table 2_Galunisertib attenuates pulmonary fibrosis with silicosis in mouse via TGF-β/TRAF6/Beclin1 signaling pathway.xlsx

Table 2_Galunisertib attenuates pulmonary fibrosis with silicosis in mouse via TGF-β/TRAF6/Beclin1 signaling pathway.xlsx

Objective<p>Silicosis is characterized by silicon nodules and diffuse pulmonary fibrosis. To date, no effective therapy has been developed for the treatment of silicosis. This study aimed to investigate the effects of Galunisertib, a TGF-β receptor I kinase inhibitor, on the autophagy-lysosome...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijä: Rou Li (11575418) (author)
Muut tekijät: Huimin Kang (435951) (author), Aoxiang Hu (22679153) (author), Guo Chen (182090) (author), Tinghua Yan (18786622) (author), Ting Liu (45625) (author), Shi Chen (120917) (author)
Julkaistu: 2025
Aiheet:
Pharmacology
Galunisertib
silicosis
TGF-β
autophagy
fibrosis
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia

Samankaltaisia teoksia